Blog / News

12 Apr 2023

“Cracking Covid: The history of COG-UK” online exhibition

We are pleased to share the news that the online exhibition “Cracking Covid: The history of COG-UK” is now live and can be found here.

The exhibition is curated by Dr Lara Marks, a noted historian of medicine and biotechnology, who has spent the last year conducting in depth interviews with more than 80 consortium members and synthesising their experiences into a compelling narrative that tells the story of the consortium and its members set against the backdrop of the pandemic as it emerged and developed.

The exhibition reflects the varied range of individual backgrounds and expertise that contributed to the consortium and aims to provide a valuable resource for people to consider what COG-UK achieved, how we achieved it, and what lessons this might hold for the future. It is intentionally pitched to be accessible to non-expert readers, and as noted by Lara, can only begin to scratch the surface of the full history of COG-UK.

We hope that the resulting exhibition will provide a lasting resource for people to look back at what we achieved together and a place where they can draw upon our collected experiences to help tackle future pandemic threats and deliver large-scale collaborative initiatives.

Visit the online exhibition here.

COVID-19 Genomics UK (COG-UK)

The COVID-19 Genomics UK (COG-UK) consortium works in partnership to harness the power of SARS-CoV-2 genomics in the fight against COVID-19.

Led by Professor Sharon Peacock of the University of Cambridge, COG-UK is made up of an innovative collaboration of NHS organisations, the four public health agencies of the UK, the Wellcome Sanger Institute and sixteen academic partners. A full list of collaborators can be found here.

The COVID-19 pandemic, caused by SARS-CoV-2, represents a major threat to health. The COG-UK consortium was formed in March 2020 to deliver SARS-CoV-2 genome sequencing and analysis to inform public health policy and to support the establishment of a national pathogen sequencing service, with sequence data now predominantly generated by the Wellcome Sanger Institute and the Public Health Agencies.

SARS-CoV-2 genome sequencing and analysis plays a key role in the COVID-19 public health response by enabling the identification, tracking and analysis of variants of concern, and by informing the design of vaccines and therapeutics. COG-UK works collaboratively to deliver world-class research on pathogen sequencing and analysis, maximise the value of genomic data by ensuring fair access and data linkage, and provide a training programme to enable equity in global sequencing.